scholarly journals Alectinib as a treatment option following recovery from crizotinib-induced interstitial lung disease in patients with anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

2016 ◽  
Vol 4 (6) ◽  
pp. 1085-1087 ◽  
Author(s):  
SHIGENARI NUKAGA ◽  
KATSUHIKO NAOKI ◽  
TETSURO KAMO ◽  
KEITA MASUZAWA ◽  
HIROYUKI YASUDA ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document